Wellington Management Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,889
Closed -$2.56M 2365
2017
Q4
$2.56M Sell
1,889
-911
-33% -$26K ﹤0.01% 1657
2017
Q3
$1.71M Buy
+2,800
New +$64.2K ﹤0.01% 1754

Wellington Management Group's ARNA Position: Q1 2022 in Review

Wellington Management Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 3,882,502 shares — an estimated $361M sold.

Wellington Management Group first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $579M in Q2 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Wellington Management Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Wellington Management Group sold 3,882,502 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $361M.
  • Wellington Management Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
  • Wellington Management Group's Arena Pharmaceuticals Inc position peaked at $579M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.